Electronic Records
Beyond the clinic: An AI-enabled digital platform for type 2 diabetes
October 30, 2026
VANCOUVER – In a three-month BC Ministry of Health-supported pilot that tested D2Type, a platform for prediabetics and patients with type 2 diabetes, participants with type 2 diabetes showed improvements in glycemic control, weight and lifestyle behaviours. Mean HbA1c fell by 0.9 percentage points, and half lost at least five percent of their body weight.
The findings were published in Diabetes and presented at the American Diabetes Association Scientific Sessions in 2025.
Building on that pilot, D2Type is now moving toward routine care at greater scale. With support from Innovate BC, the company is working with the Jim Pattison Centre for Health System Learning and Innovation and Interior Health on implementation in community and primary care settings, preparing for broader adoption in British Columbia.
D2Type is a platform consisting of three connected tools that deliver lifestyle-first care: guiding patients, surfacing risk early, and keeping clinicians aligned between visits.
- D2Type Companion is a patient-friendly app that seamlessly tracks lifestyle metrics and delivers timely, coach-supported guidance to keep members on track. The app may tell the patient, “Great to see your blood glucose drop this week!”
- D2Type Beacon, an AI signal and triage layer detecting risk early and recommending next-best actions, so care reaches the right person at the right time. Observing the patient’s movements, it might note: “Let’s add a little more physical activity this week.”
- D2Type Hub, a shared dashboard enabling coaches and clinicians to monitor progress and adjust care between visits, without added team burden. Clinicians, for example, can view charts showing the patient’s improvement or decline over time.
D2Type is designed to help alleviate the growth of diabetes in Canada by assisting both patients and caregivers.
Nearly 12 million people in Canada are living with diabetes or prediabetes. For a healthcare system under pressure, the challenge is not simply diagnosis and treatment. Much of diabetes care happens after the appointment ends.
A person may see a healthcare professional only a handful of times a year. Between those visits, they make hundreds of small decisions every day – what to eat, whether to be active, how well to sleep, how to manage stress and what to do when glucose or weight changes. Over time, those decisions shape not only diabetes control, but broader cardiometabolic health.
Clinicians understand this, but primary care teams are already stretched. Where resources are available, patients may receive education and follow-up from diabetes nurses, dietitians and other professionals. Even then, most day-to-day decisions happen between appointments, outside the care team’s view. Clinicians cannot realistically review every meal, activity pattern, sleep change or glucose reading, nor do they want another dashboard added to a busy workflow.
That is the care gap Vancouver-based D2Type Health is trying to address.
D2Type is a digital care platform for people with prediabetes and type 2 diabetes, built with a broader cardiometabolic view. Because diabetes often sits alongside issues such as excess weight, blood pressure and lipid abnormalities, the platform looks beyond glucose alone.
For patients, D2Type brings together information on nutrition, physical activity, sleep, stress, weight, glucose, medications and engagement. The aim is not simply to collect data, but to turn it into practical next actions that fit real life.
Those actions change at different time horizons. In the moment, the platform can help someone make a better choice around food or activity. At the end of the day, it can highlight a pattern worth noticing. Each week, it can narrow many possible goals into a small number of personalized priorities.
Over longer periods, it can show whether those changes are being sustained and whether the plan needs to adapt.
Artificial intelligence supports this process in the background. Rather than giving everyone the same advice, the system looks at patterns across different data streams and how an individual responds over time.
If a suggestion is followed and appears useful, the platform can build on it. If it is difficult to sustain or no longer relevant, the next action can change.
This creates a more adaptive approach to behaviour change. Two people with similar HbA1c levels may need different support because their patterns, barriers and previous responses are different. The intent is to keep recommendations personal and dynamic rather than static or generic. Human coaches can review and adjust weekly plans, while clinical decisions remain with healthcare professionals.
D2Type is not designed around a physician or nurse monitoring every daily data point. Instead, it summarizes longer-term trends and brings forward selected information that may deserve attention. This can help care teams see who is progressing, who may be disengaging and who may benefit from earlier follow-up.
D2Type tries to connect two parts of care that are often separated: the everyday decisions people make outside the clinic and the limited time healthcare professionals have to support them.
If digital platforms can make the weeks and months between appointments more visible, personalized and actionable, cardiometabolic care could become more continuous – extending support beyond the clinic walls without asking clinicians to do more of everything.
Ameneh Madjd, PhD is co-founder & COO of D2Type Health Inc.